111 related articles for article (PubMed ID: 29383112)
1. Unique circulating microRNAs in relation to EGFR mutation status in Japanese smoker male with lung adenocarcinoma.
Ito S; Kamoto Y; Sakai A; Sasai K; Hayashi T; Toyooka S; Katayama H
Oncotarget; 2017 Dec; 8(70):114685-114697. PubMed ID: 29383112
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs in relation to EGFR status and survival of lung adenocarcinoma in female non-smokers.
Zhang H; Su Y; Xu F; Kong J; Yu H; Qian B
PLoS One; 2013; 8(11):e81408. PubMed ID: 24282590
[TBL] [Abstract][Full Text] [Related]
3. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach.
Yan L; Jiao D; Hu H; Wang J; Tang X; Chen J; Chen Q
Exp Biol Med (Maywood); 2017 Apr; 242(7):709-717. PubMed ID: 28299977
[TBL] [Abstract][Full Text] [Related]
4. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
5. Unique MicroRNA and mRNA Interactions in
Subat S; Inamura K; Ninomiya H; Nagano H; Okumura S; Ishikawa Y
J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30404194
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
7. Plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI.
Ma Y; Pan X; Xu P; Mi Y; Wang W; Wu X; He Q; Liu X; Tang W; An HX
Oncotarget; 2017 Oct; 8(51):88529-88536. PubMed ID: 29179454
[TBL] [Abstract][Full Text] [Related]
8. Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation.
Wang S; Su X; Bai H; Zhao J; Duan J; An T; Zhuo M; Wang Z; Wu M; Li Z; Zhu J; Wang J
J Hematol Oncol; 2015 Nov; 8():127. PubMed ID: 26563758
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
10. Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder.
Wan Y; Liu Y; Wang X; Wu J; Liu K; Zhou J; Liu L; Zhang C
PLoS One; 2015; 10(3):e0121975. PubMed ID: 25763923
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
12. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
Lian F; Cui Y; Zhou C; Gao K; Wu L
PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
[TBL] [Abstract][Full Text] [Related]
13. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
14. Analysis of plasma microRNA expression profiles in male textile workers with noise-induced hearing loss.
Ding L; Liu J; Shen HX; Pan LP; Liu QD; Zhang HD; Han L; Shuai LG; Ding EM; Zhao QN; Wang BS; Zhu BL
Hear Res; 2016 Mar; 333():275-282. PubMed ID: 26278637
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 Deletion.
Ju L; Han M; Li X; Zhao C
J Cancer; 2017; 8(7):1311-1318. PubMed ID: 28607607
[TBL] [Abstract][Full Text] [Related]
16. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
17. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer.
Pu Q; Huang Y; Lu Y; Peng Y; Zhang J; Feng G; Wang C; Liu L; Dai Y
Thorac Cancer; 2016 Apr; 7(3):348-54. PubMed ID: 27148421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
